-
Therapeutic inhibition of excessive lung inflammation induced by...
Therapeutic inhibition of excessive lung inflammation induced by anti-SARS-CoV-2 antibodies -
Preclinical development of an antiviral small molecule drug against COVID-19
Preclinical development of an antiviral small molecule drug against COVID-19 -
COVID19 Outcomes in Older People - the COOP study
Follow-up: questionnaires and data enrichment (CFS) -
Vaccinating children with Long-COVID to improve overall fitness
Vaccinating children with Long-COVID to improve overall fitness -
CovId-19 en SOciale isoLATie in de dEmentiezorg (ISOLATE): impact en...
CovId-19 en SOciale isoLATie in de dEmentiezorg (ISOLATE): impact en behoeften van mensen met dementie, mantelzorgers en zorgmedewerkers -
General practice Research Infrastructure Pandemic Preparedness Program (GRIP3) WP1
General practice Research Infrastructure Pandemic Preparedness Program (GRIP3) WP1 -
National and regional coordination in times of scarcity
National and regional coordination in times of scarcity; Landelijke en regionale coordinatie in tijden van schaarste -
Safe and Timely Cessation of Isolation of Patients with COVID-19, The...
Safe and Timely Cessation of Isolation of Patients with COVID-19, The SCIP-COVID-19 study -
De neurobiologische basis van aanhoudende Vermoeidheid en Cognitieve...
De neurobiologische basis van aanhoudende Vermoeidheid en Cognitieve klachten na COVID-19 -
Caging the dragon: translational approach to unravel and prevent COVID-19...
Caging the dragon: translational approach to unravel and prevent COVID-19 associated thrombosis (10430012010004) -
Therapeutic inhibition of excessive lung inflammation induced by...
Therapeutic inhibition of excessive lung inflammation induced by anti-SARS-CoV-2 antibodies -
COVID-19 and ischemic stroke - How to tame a dozing monster
COVID-19 and ischemic stroke - How to tame a dozing monster -
Prospective cohort study of non-hospitalised COVID-19 patients: determining...
Prospective cohort study of non-hospitalised COVID-19 patients: determining length of isolation and patient clinical development at home (COVID-HOME study) -
SARS-CoV-2 and other virus infections; interference, synergy or both?
SARS-CoV-2 and other virus infections; interference, synergy or both? -
Frequency of opportunistic pathogens in Covid-19 and their impact on clinical outcome
Frequency of opportunistic pathogens in Covid-19 and their impact on clinical outcome -
Inrichting van een organisatie- en infrastructuur voor onderzoeksgroep...
De Harmony data en documentatie zijn beschikbaar in het Data Station voor Life Sciences -
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de...
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC) -
A double-blind, placebo-controlled randomized clinical trial with valsartan...
A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2... -
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A...
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulines -
Establishment and duration of protective immunity against SARS-CoV-2 in...
Establishment and duration of protective immunity against SARS-CoV-2 in relation to severity of SARS-CoV-2 infection.; Establishment and duration of protective immunity against...